-

National Institutes of Health Awards Aural Analytics $1.4M Grant

Aural Analytics’ Speech Vitals technology delivers clinical-grade speech analytics

PHOENIX--(BUSINESS WIRE)--Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today it was awarded a $1.4 million grant from the National Institutes of Health. The grant supports Aural Analytics’ development of a tool speech-language pathologists can use to improve their clinical workflow.

“The timing of this grant couldn’t be better because it further fuels Aural Analytics’ Speech Vitals technology to measure speech,” said Judy Smythe, CEO of Aural Analytics. “We have built our clinical speech analytics technology pipeline from the ground up and are now focused on validating our metrics against clinical benchmarks. Today, Speech Vitals is being used in 30 concurrent clinical studies, a signal not just of the trend of mining speech, but Aural Analytics’ place at the forefront of it.”

Speech-language pathologists are trained to perceive, describe, and rate aspects of the speech signal that are not often thought about. But this subjective evaluation of speech has major limitations. Speech Vitals overcomes these limitations by analyzing the speech objectively and in finer resolution than the human ear can perceive. These objective results are reliable and repeatable and are designed to capture clinically meaningful information in the speech signal.

To learn more about Aural Analytics and its Speech Vitals technology, visit www.auralanalytics.com.

About Aural Analytics, Inc.

Aural Analytics is the industry’s leading speech neuroscience company harnessing the clinical utility of the world’s speech across the age range and around the world. Their suite of applications and embeddable SDKs and APIs, available in 22 languages across Android, iOS, and the web, are easy to use, secure, and provide robust, clinically relevant, interpretable, and validated metrics reflecting the neurological and respiratory health of its users. For more information, please visit auralanalytics.com or follow Aural Analytics on Twitter, LinkedIn, Medium, and Facebook.

Contacts

Paulo Acuña
310.824.9000
pacuna@olmsteadwilliams.com

More News From Aural Analytics, Inc.

Aural Analytics Awarded Key ISO Certifications for its Clinical-Grade Speech Analytics

PHOENIX--(BUSINESS WIRE)--Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced it was awarded certification to ISO 9001: 2015, a general quality management system certification that covers the non-medical device usage of its speech analytics product, and ISO 13485: 2016, a quality management standard that includes specific requirements for medical devices. The certifications demonstrate the company’s dedication to upholding global standards for quality assurance a...

FDA Registers Aural Analytics Clinical-Grade Speech Analytics as a Computerized Cognitive Assessment Aid

PHOENIX--(BUSINESS WIRE)--Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced US Food and Drug Administration (FDA) registration for its clinical-grade speech analytics product, Speech Vitals, as a computerized cognitive assessment aid, a class II software medical device (SaMD). FDA registration strengthens Speech Vitals’ objective, reliable, generalizable, and repeatable approach to speech analytics, made possible by its clinically and analytically validated mea...

Aural Analytics and HitCheck Partner to Use Clinical-Grade Speech Analytics to Measure Athletes’ Brain Health After Taking a Hit on the Field

PHOENIX--(BUSINESS WIRE)--Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced a partnership with HitCheck to solve in-game concussion protocol decision-making. HitCheck’s cognitive assessment application tracks individuals’ unique performance over time and screens for sudden changes after a potential brain injury has occurred. Aural Analytics’ clinical-grade speech analytics are now embedded into HitCheck’s app, enriching the assessments that coaches, athletes, m...
Back to Newsroom